At Neuro-Bio, we’re thrilled at entering this next phase of development with Aptamer Group: the first phase proved productive and very promising. Now, this next stage takes us closer to realising a highly novel and much needed technology for detecting...
Aging US published Neuro-Bio’s paper in collaboration with Unilever on June 28, 2023, entitled, “A novel peptide ‘T14’ reflects age and photo-aging in human skin.” Click here to read the full paper. A video summary is able to watch below....
We are delighted to share that the full recording of our Panel Discussion at the Royal College of Physicians is now available to view. This discussion is focused on new insights into the process of Neurodegeneration and developing a Pre-Symptomatic Biomarker for...
Neuro-Bio is delighted to continue its cooperation with Professor Zoltan Molnar’s laboratory and to announce that Sara Bandiera will be characterising T14 in the developing brain during a fix-term collaboration. Sara originally come from Italy, where she studied...
Neuro-Bio is delighted to announce that Clota Varde will be supporting its Series C £10 M fundraise. Neuro-Bio and Clota Varde team met in December 2022 and have now officially started their collaboration. This is what the Clota Varde team said after visiting...
Neuro-Bio has launched a new webpage called “Allies of Neuro-Bio” in which people living with Alzheimer’s Disease and their careers can send their thoughts. Neuro-Bio will only be able to post a limited number and the page will simply be a notice board,...
